Meeting
2018 ASCO Annual Meeting
Frequency of overexpression of HER3 and prognostic consequences in European patients with early gastric cancer.
Authors
Nieves Martinez Lago
Hospital Clinico de Santiago de Compostela, Santiago De Compostela, Spain
Nieves Martinez Lago , Ihab Abdulkader Nallib , Maria Vieito , Juan Jose Carrera , Sonia Candamio Folgar , Yolanda Vidal Insua , Francisca Vazquez Rivera , Jose Ramón Antunez Lopez , Rafael López López , Maria Elena Padin Iruegas
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Esophageal or Gastric Cancer
Citation
J Clin Oncol 36, 2018 (suppl; abstr 4068)
DOI
10.1200/JCO.2018.36.15_suppl.4068
Abstract #
4068
Poster Bd #
257
Abstract Disclosures
Similar Posters
Poster
2018 Gastrointestinal Cancers Symposium
Assessment and prognostic impact of a new classification using HER2 and HER3 status in resected gastric cancer in a european cohort.
First Author: Nieves Martinez Lago
Poster
2015 Gastrointestinal Cancers Symposium
Discordances in HER2 status between primary gastric cancer and corresponding metastatic sites.
First Author: Ozge Gumusay
Poster
2024 ASCO Gastrointestinal Cancers Symposium
The expanded indications of HER2-targeted therapies by monitoring of circulating tumor cells.
First Author: Yasuaki Kimura
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Clinicopathological features of HER2-low expressed advanced gastric cancers.
First Author: Izuma Nakayama